TXG logo

10x Genomics (TXG) Cash from investing

annual CFI:

-$32.63M-$166.12M(-124.44%)
December 31, 2024

Summary

  • As of today (June 2, 2025), TXG annual cash flow from investing activities is -$32.63 million, with the most recent change of -$166.12 million (-124.44%) on December 31, 2024.
  • During the last 3 years, TXG annual CFI has risen by +$74.10 million (+69.43%).
  • TXG annual CFI is now -124.44% below its all-time high of $133.49 million, reached on December 31, 2023.

Performance

TXG Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

quarterly CFI:

-$1.89M+$49.70M(+96.33%)
March 31, 2025

Summary

  • As of today (June 2, 2025), TXG quarterly cash flow from investing activities is -$1.89 million, with the most recent change of +$49.70 million (+96.33%) on March 31, 2025.
  • Over the past year, TXG quarterly CFI has dropped by -$12.53 million (-117.80%).
  • TXG quarterly CFI is now -101.58% below its all-time high of $119.96 million, reached on March 31, 2023.

Performance

TXG quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

TTM CFI:

-$45.16M-$12.53M(-38.38%)
March 31, 2025

Summary

  • As of today (June 2, 2025), TXG TTM cash flow from investing activities is -$45.16 million, with the most recent change of -$12.53 million (-38.38%) on March 31, 2025.
  • Over the past year, TXG TTM CFI has dropped by -$69.32 million (-286.84%).
  • TXG TTM CFI is now -133.83% below its all-time high of $133.49 million, reached on December 31, 2023.

Performance

TXG TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TXG Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-124.4%-117.8%-286.8%
3 y3 years+69.4%+99.3%+85.9%
5 y5 years+23.7%+76.6%-8.9%

TXG Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-124.4%+90.7%-101.6%+99.3%-133.8%+87.1%
5 y5-year-124.4%+90.7%-101.6%+99.3%-133.8%+87.1%
alltimeall time-124.4%+90.7%-101.6%+99.3%-133.8%+87.1%

TXG Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$1.89M(-96.3%)
-$45.16M(+38.4%)
Dec 2024
-$32.63M(-124.4%)
-$51.59M(+1326.0%)
-$32.63M(-201.8%)
Sep 2024
-
-$3.62M(-130.3%)
$32.06M(-21.0%)
Jun 2024
-
$11.95M(+12.4%)
$40.58M(+67.9%)
Mar 2024
-
$10.63M(-18.8%)
$24.17M(-81.9%)
Dec 2023
$133.49M(-138.0%)
$13.10M(+167.3%)
$133.49M(+53.0%)
Sep 2023
-
$4.90M(-209.8%)
$87.22M(+75.5%)
Jun 2023
-
-$4.46M(-103.7%)
$49.69M(+86.6%)
Mar 2023
-
$119.96M(-461.6%)
$26.63M(-107.6%)
Dec 2022
-$350.89M(+228.8%)
-$33.17M(+1.7%)
-$350.89M(+1.6%)
Sep 2022
-
-$32.63M(+18.5%)
-$345.33M(+3.7%)
Jun 2022
-
-$27.53M(-89.3%)
-$332.93M(+4.1%)
Mar 2022
-
-$257.56M(+832.6%)
-$319.97M(+199.8%)
DateAnnualQuarterlyTTM
Dec 2021
-$106.73M(+178.0%)
-$27.62M(+36.5%)
-$106.73M(+5.3%)
Sep 2021
-
-$20.23M(+38.8%)
-$101.38M(+22.9%)
Jun 2021
-
-$14.57M(-67.1%)
-$82.46M(+10.5%)
Mar 2021
-
-$44.32M(+99.0%)
-$74.63M(+94.4%)
Dec 2020
-$38.39M(-10.2%)
-$22.27M(+1599.7%)
-$38.39M(+69.1%)
Sep 2020
-
-$1.31M(-80.6%)
-$22.71M(-35.3%)
Jun 2020
-
-$6.74M(-16.6%)
-$35.08M(-15.4%)
Mar 2020
-
-$8.08M(+22.8%)
-$41.48M(-3.0%)
Dec 2019
-$42.77M(+537.5%)
-$6.58M(-51.9%)
-$42.77M(+18.2%)
Sep 2019
-
-$13.68M(+4.1%)
-$36.19M(+60.8%)
Jun 2019
-
-$13.14M(+40.3%)
-$22.51M(+140.3%)
Mar 2019
-
-$9.37M
-$9.37M
Dec 2018
-$6.71M(+78.6%)
-
-
Dec 2017
-$3.76M
-
-

FAQ

  • What is 10x Genomics annual cash flow from investing activities?
  • What is the all time high annual CFI for 10x Genomics?
  • What is 10x Genomics annual CFI year-on-year change?
  • What is 10x Genomics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for 10x Genomics?
  • What is 10x Genomics quarterly CFI year-on-year change?
  • What is 10x Genomics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for 10x Genomics?
  • What is 10x Genomics TTM CFI year-on-year change?

What is 10x Genomics annual cash flow from investing activities?

The current annual CFI of TXG is -$32.63M

What is the all time high annual CFI for 10x Genomics?

10x Genomics all-time high annual cash flow from investing activities is $133.49M

What is 10x Genomics annual CFI year-on-year change?

Over the past year, TXG annual cash flow from investing activities has changed by -$166.12M (-124.44%)

What is 10x Genomics quarterly cash flow from investing activities?

The current quarterly CFI of TXG is -$1.89M

What is the all time high quarterly CFI for 10x Genomics?

10x Genomics all-time high quarterly cash flow from investing activities is $119.96M

What is 10x Genomics quarterly CFI year-on-year change?

Over the past year, TXG quarterly cash flow from investing activities has changed by -$12.53M (-117.80%)

What is 10x Genomics TTM cash flow from investing activities?

The current TTM CFI of TXG is -$45.16M

What is the all time high TTM CFI for 10x Genomics?

10x Genomics all-time high TTM cash flow from investing activities is $133.49M

What is 10x Genomics TTM CFI year-on-year change?

Over the past year, TXG TTM cash flow from investing activities has changed by -$69.32M (-286.84%)
On this page